EP1950199 - Bibliographic data

Proline derivatives and use thereof as drugs

Last update 14/06/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

MITSUBISHI TANABE PHARMA CORPORATION

2-10, Dosho-machi 3-chome
Chuo-ku Osaka-shi Osaka 541-8505
Japon
(72) Inventors

Kitajima, Hiroshi

c/o Mitsubishi Tanabe Pharma Corporation 2-6, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8405
Japon

Sakashita, Hiroshi

c/o Mitsubishi Tanabe Pharma Corp. 2-6, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8405
Japon

Akahoshi, Fumihiko

c/o Mitsubishi Tanabe Pharma Corp. 2-6, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8405
Japon

Hayashi, Yoshiharu

c/o Mitsubishi Tanabe Pharma Corp. 2-6, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8405
Japon
(74) Agent

Mail recipient

VON KREISLER SELTING WERNER

Patentanwälte Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln
Allemagne

(21) Request number EP08001976.3
(22) Request date 10/08/2001

(11) Publication number EP1950199
Publication date 02/12/2009

(54) Title of the invention Proline derivatives and use thereof as drugs
(51) International classification C07D 207/16C07D 401/14C07D 403/14C07D 413/14C07D 417/14C07D 487/10C07D 471/10A61K 31/401A61P 3/00A61P 43/00
International classification (before reform) None

Claimed priority

(31) Number: 2000243217
(32) Date: 10/08/2000
(33) Country: JP


(31) Number: 2000400296
(32) Date: 28/12/2000
(33) Country: JP

Initial application None
Divisional application None

Expected annuity Annuity: 10 - Amount: 135 € - Due date 31/08/2010
Surtax: 10 - Amount: 27 € - Due date 01/03/2011
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2009/4, of 31/12/2009

History

Publication de la délivrance du brevet européen - Legal date 02/12/2009


Déchéance du brevet d'invention après période de grâce - Legal date 31/08/2011


Entrée en période de grâce du brevet d'invention - Legal date 31/08/2010